Fact CheckerSign in

NCT07589387Recruiting

Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3

Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design - Aim 3

Source: ClinicalTrials.gov · Last updated 16 Oct 2026

Brief summary (registry, in English)

The purpose of the second phase of the Hypertension Treatment in Nigeria (HTN 2.0) Program is to build upon the success of the first phase of the HTN Program (2020-2023), which implemented the WHO HEARTS package across 60 primary healthcare centers (PHCs) in the Federal Capital Territory (FCT). This program demonstrated significant improvements in hypertension treatment and control. The focus of aim 3 will be evaluating diabetes management through the implementation of the HEARTS-D bundle in 10 PHCs across the FCT that previously participated in the initial HTN Program.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
2800 (estimated)
First submitted
29 Apr 2026
Start date
14 Feb 2026
Primary completion date
30 Apr 2029
Lead sponsor
Washington University School of Medicine
NCT number
NCT07589387

What you commit to

  • Study type: Interventional
  • Planned participants: 2800
  • From 14 Feb 2026 to the primary completion date, 30 Apr 2029
  • 10 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • \- This program will not include any of the following special populations:
    • Individuals who are not yet adults (minors): i.e. infants, children, or teenagers \<18 years old, or
    • Prisoners or other detained individuals.

Who the study is looking for

  • Aim 3 Inclusion Criteria:
    • Patients will be screened for diabetes with symptoms of hyperglycemia or BMI \>25 kg/m2 and over the age of 18 years old. Upon first or previous diagnosis, diabetes patients will be registered.
  • Adults (≥18 years),
  • Patients with previous diabetes diagnosis
  • Patients with persistently elevated random glucose \>200 mg/dl, fasting glucose \>126 mg/dl, or hemoglobin A1c \>6.5% on two or more occasions (when available)
  • Patients taking glucose lowering medications
  • Pregnant women are eligible for this program, or
  • Cognitively impaired adults are eligible for this program.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (10)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
New Township Abaji
Coordinator of this site? Confirm its status
AbajiNigeriaRecruiting
Gidan Mangoro
Coordinator of this site? Confirm its status
AbujaNigeriaRecruiting
Gbagarape PHC
Coordinator of this site? Confirm its status
AbujaNigeriaRecruiting
Pyakasa PHC
Coordinator of this site? Confirm its status
AbujaNigeriaRecruiting
Byazhin
Coordinator of this site? Confirm its status
BwariNigeriaRecruiting
Gtc Gwagwalada
Coordinator of this site? Confirm its status
GwagwaladaNigeriaRecruiting
Old Kutunku
Coordinator of this site? Confirm its status
GwagwaladaNigeriaRecruiting
Kuje PHC
Coordinator of this site? Confirm its status
KujeNigeriaRecruiting
Dabi Bako
Coordinator of this site? Confirm its status
KwaliNigeriaRecruiting
KAWLI
Coordinator of this site? Confirm its status
KwaliNigeriaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.